Founded in 1996, Impulse Dynamics is a medical device company dedicated to offering innovative solutions for treatment of Chronic Heart Failure (CHF). The Company’s developments are based on its proprietary technology for administrating Cardiac Contractility Modulation (CCM) therapy. This form of treatment has been shown in clinical trials to produce an immediate and powerful modulating effect on cardiac cells, resulting in a significant increase in cardiac performance.
Impulse Dynamics is spearheaded by a team of professionals including, scientists, physicians, and engineers. The Company carries out research programs in major universities and hospitals throughout the world, and is currently engaged in clinical trials in Europe and in the United States. The Optimizer with CCM therapy, is CE marked and is in the final stages of clinical evaluation to support FDA approval. See Clinical Sites for more information.
The Optimizer, the Company’s first product, has been successfully launched in Europe, and has been implanted in over 1,500 patients with over 8 years of follow-up data available. Clinical trials have shown the device is safe, and significantly improves exercise tolerance and quality of life in treated patients.
The Company’s operations are spread throughout the globe, with corporate headquarters in the Netherlands Antilles, New York based US operations, and Germany based EU operations (Stuttgart).
Search the Site
- 8. – 11. April 2015 The 81th Annual Meeting of the German Society of Cardiology (DGK), Mannheim, Germany
- 23. – 26. May 2015 Heartfailure 2015
- 21. – 24. June 2015 Cardiostim
- 29. August – 2. September 2015 ESC
- 8. – 10. Oktober 2015 German Cardiology Society’s Autumn Meeting 2015, Düsseldorf